Research programme: micelle nanoparticle therapeutics - NanoCarrier

Drug Profile

Research programme: micelle nanoparticle therapeutics - NanoCarrier

Alternative Names: Docetaxel micelle; Medicelle®; protein micelle; Sensor linked micelle; siRNA micelle

Latest Information Update: 04 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator NanoCarrier
  • Developer JCR Pharmaceuticals; NanoCarrier
  • Class Antibodies; Boronic acids; Polymers; Proteins; Pyrazines; Small interfering RNA; Small molecules; Taxanes
  • Mechanism of Action Apoptosis stimulants; Biological factor modulators; Immunomodulators; Mitosis inhibitors; Proteasome inhibitors; RNA interference; Tubulin modulators; Tubulin polymerisation promoters
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Research Brain disorders
  • No development reported Cancer; Haemophilia; Unspecified

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for research development in Cancer in Japan (Parenteral)
  • 04 Nov 2017 No recent reports of development identified for research development in Haemophilia in Japan (Parenteral)
  • 04 Nov 2017 No recent reports of development identified for research development in Undefined in Japan (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top